Avalon GloboCare Corp.ALBT
| Dec 31,
2015 | Dec 31,
2016 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 |
|---|
| Real property rental | - | - | - | - | - | - | 1 | 1 |
|---|
| Medical related consulting services - related party | - | - | - | - | - | - | 187,412 | - |
|---|
| Total Revenues | - | 616,446 | 1 | 2 | 2 | 1 | 1 | 1 |
|---|
| Real property operating expenses | - | - | - | - | - | - | 829,287 | 929,441 |
|---|
| Medical related consulting services - related party | - | - | - | - | - | - | 147,167 | - |
|---|
| Total Costs and Expenses | - | - | 829,787 | 1 | 1 | 987,559 | 976,454 | 929,441 |
|---|
| Real property operating income | - | - | - | - | - | - | -374,273 | -272,728 |
|---|
| Gross profit from medical related consulting services | - | 616,446 | 828,663 | 1 | 1 | 1 | 40,245 | - |
|---|
| Total Gross Profit | - | 543,380 | 49,789 | -18,967 | 339,913 | 390,203 | 414,518 | 272,728 |
|---|
| Advertising and marketing | - | - | - | - | - | - | - | 1 |
|---|
| Professional fees | - | 395,780 | 1 | 3 | - | 7 | 5 | 3 |
|---|
| Compensation and related benefits | - | - | 1 | 3 | 9 | 4 | 2 | 2 |
|---|
| Research and development expenses | - | - | - | - | 2 | 883,855 | 1 | 731,328 |
|---|
| Litigation settlement | - | - | - | - | - | - | - | 1 |
|---|
| Other general and administrative | - | 63,773 | 464,544 | 1 | 8 | 1 | 1 | 886,142 |
|---|
| Total Other Operating Expenses | 31,006 | 466,447 | 4 | 8 | 20 | 13 | 9 | 9 |
|---|
| LOSS FROM OPERATIONS | -31,006 | 76,933 | -3,877,863 | -7,631,135 | -19,377,230 | -12,454,019 | -8,833,830 | -8,792,895 |
|---|
| Interest expense- amortization of debt discount and debt issuance cost | - | - | - | - | - | - | - | 3 |
|---|
| Interest expense- other | - | - | - | - | - | - | - | 185,751 |
|---|
| Interest expense - related party | - | - | - | - | 49,194 | - | 200,477 | 79,898 |
|---|
| Conversion inducement expense | - | - | - | - | - | - | - | 344,264 |
|---|
| Loss from equity method investment | - | - | - | -52,969 | -55,776 | -51,673 | - | -41,863 |
|---|
| Change in fair value of derivative liability | - | - | - | - | - | - | - | 600,749 |
|---|
| Other income | - | 575 | -171,782 | -11,345 | 3,262 | -4,984 | 4,271 | 223,759 |
|---|
| Total Other Expense, net | - | - | - | -421,161 | 1 | -225,419 | -256,669 | -3,137,952 |
|---|
| LOSS BEFORE INCOME TAXES | - | - | -4,049,645 | -8,052,296 | -18,070,161 | -12,679,438 | -9,090,499 | -11,930,847 |
|---|
| Total income taxes expense | - | 21,927 | - | - | - | - | - | - |
|---|
| NET LOSS | -31,006 | 55,581 | -4,049,645 | -8,052,296 | -18,070,161 | -12,679,438 | -9,090,499 | -11,930,847 |
|---|
| NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS | - | - | - | - | - | - | -9,090,499 | -11,930,847 |
|---|
| NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS | - | - | - | - | - | - | - | -11,930,847 |
|---|
| Unrealized foreign currency translation (loss) gain | - | - | - | - | - | - | - | 47,871 |
|---|
| COMPREHENSIVE LOSS | - | - | -3,461,711 | -7,918,988 | -18,091,048 | -12,612,201 | -9,065,255 | -11,978,718 |
|---|
| COMPREHENSIVE LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS | - | -38,987 | -4,047,105 | -8,195,794 | -18,091,048 | -12,612,201 | -9,065,255 | -11,978,718 |
|---|
| Basic and diluted (in Dollars per share) | - | - | - | - | - | - | - | -1.28 |
|---|